Risk of Cardiovascular Disorders in Psoriasis Patients

Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis

(2012) J. Ahdout et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Psoriasis and cardiovascular risk. Assessment by different cardiovascular risk scores

(2012) R. Fernández-Torres et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

To Be 17 Again — Anti–Interleukin-17 Treatment for Psoriasis

(2012) Ari Waisman   NEW ENGLAND JOURNAL OF MEDICINE

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

(2012) Kim A. Papp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

(2012) Craig Leonardi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study

(2011) K. Abuabara et al.   BRITISH JOURNAL OF DERMATOLOGY

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies

(2011) K. Reich et al.   BRITISH JOURNAL OF DERMATOLOGY

Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study

(2011) Ole Ahlehoff et al.   EUROPEAN HEART JOURNAL

A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis

(2011) April W. Armstrong et al.   EXPERIMENTAL DERMATOLOGY

Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events

(2011) Caitriona Ryan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)

(2011) Tsen-Fang Tsai et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Psoriasis and Cardiovascular Risk: Strength in Numbers, Part II

(2011) Joel M. Gelfand et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Usefulness of the Framingham Risk Score in Patients With Chronic Psoriasis

(2010) Paolo Gisondi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Prevalence of the Metabolic Syndrome in Psoriasis

(2010) Thorvardur Jon Love et al.   ARCHIVES OF DERMATOLOGY

Epidemiology of comorbidities in psoriasis

(2010) Luigi Naldi et al.   Dermatologic Therapy

Ustekinumab

(2010) Oya Cingoz   mAbs

Association of Psoriasis With Coronary Artery, Cerebrovascular, and Peripheral Vascular Diseases and Mortality

(2009) Srjdan Prodanovich et al.   ARCHIVES OF DERMATOLOGY

Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells

(2009) Raymond E. Eid et al.   CIRCULATION

Functional characterization of T cells differentiated in vitro from bone marrow-derived CD34+ cells of psoriatic patients with family history

(2009) Kaiming Zhang et al.   EXPERIMENTAL DERMATOLOGY

IL-17 and Th17 cells in human inflammatory diseases

(2009) Pierre Miossec   MICROBES AND INFECTION

Psoriasis

(2009) Frank O. Nestle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis

(2008) Alexa B. Kimball   ARCHIVES OF DERMATOLOGY

Cytokines and anticytokines in psoriasis

(2008) Aldona T. Pietrzak et al.   CLINICA CHIMICA ACTA

The Th17/Treg imbalance in patients with acute coronary syndrome

(2008) Xiang Cheng et al.   CLINICAL IMMUNOLOGY

γδ T cells: an important source of IL-17

(2008) Christina L Roark et al.   CURRENT OPINION IN IMMUNOLOGY

Interplay between keratinocytes and immune cells—Recent insights into psoriasis pathogenesis

(2008) Giulia Tonel et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The molecular mechanisms of the thrombotic complications of atherosclerosis

(2008) P. Libby   JOURNAL OF INTERNAL MEDICINE

Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis

(2008) Rajan P. Nair et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Psoriasis: Improving adherence to topical therapy

(2008) Steven R. Feldman et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

(2008) Alexa B. Kimball et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

(2008) Craig L Leonardi et al.   LANCET

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

(2008) Kim A Papp et al.   LANCET